Toxicological Research : eISSN 2234-2753 / pISSN 1976-8257

Cited by CrossRef (9)

  1. Kyeong-Nam Yu, Sashi Nadanaciva, Payal Rana, Dong Woo Lee, Bosung Ku, Alexander D. Roth, Jonathan S. Dordick, Yvonne Will, Moo-Yeal Lee. Prediction of metabolism-induced hepatotoxicity on three-dimensional hepatic cell culture and enzyme microarrays. Arch Toxicol 2018;92:1295
  2. Clara Hartmanshenn, Megerle Scherholz, Ioannis P. Androulakis. Physiologically-based pharmacokinetic models: approaches for enabling personalized medicine. J Pharmacokinet Pharmacodyn 2016;43:481
  3. Jeremy A. Leonard, Yu-Mei Tan. Tiered approaches for screening and prioritizing chemicals through integration of pharmacokinetics and exposure information with in vitro dose-response data. Computational Toxicology 2019;12:100101
  4. Salil N. Pendse, Alina Efremenko, C. Eric Hack, Marjory Moreau, Pankajini Mallick, Michael Dzierlenga, Chantel I. Nicolas, Miyoung Yoon, Harvey J. Clewell, Patrick D. McMullen. Population Life-course exposure to health effects model (PLETHEM): An R package for PBPK modeling. Computational Toxicology 2020;13:100115
  5. Ok-Nam Bae, Joo Young Lee. Shedding New Lights with the Breakthrough Ideas to Understand Current Trends in Modern Toxicology. ToxicolRes 2016;32:1
  6. Yu-Mei Tan, Rachel R Worley, Jeremy A Leonard, Jeffrey W Fisher. Challenges Associated With Applying Physiologically Based Pharmacokinetic Modeling for Public Health Decision-Making. 2018;162:341
  7. Pankajini Mallick, Marjory Moreau, Gina Song, Alina Y Efremenko, Salil N Pendse, Moire R Creek, Thomas G Osimitz, Ronald N Hines, Paul Hinderliter, Harvey J Clewell, Brian G Lake, Miyoung Yoon. Development and Application of a Life-Stage Physiologically Based Pharmacokinetic (PBPK) Model to the Assessment of Internal Dose of Pyrethroids in Humans. 2020;173:86
  8. Jeffrey W. Fisher, Xiaoxia Yang, Charles Timchalk. Handbook of Developmental Neurotoxicology. 2020.
  9. Elaina M Kenyon, John C Lipscomb, Rex A Pegram, Barbara J George, Ronald N Hines. The Impact of Scaling Factor Variability on Risk-Relevant Pharmacokinetic Outcomes in Children: A Case Study Using Bromodichloromethane (BDCM). 2019;167:347